Rationale for universal precautions {#sec1}
===================================

The Acquired Immune Deficiency Syndrome (AIDS) epidemic in the 1980s caused a significant change in the delivery of healthcare, specifically gloves and gowns are now worn much more frequently. These changes essentially became the new normal and it is unlikely that a healthcare worker will examine a patients or handle a biological specimens without gloves. Initially a clear etiology for AIDS was not determined, therefore, the Center for Disease Control (CDC) published precautions for clinical and laboratory staffs in November, 1982[@bib1]. Confirmation that transmission of the human immunodeficiency virus (HIV) caused AIDS did not occur until later[@bib2].

Since the etiology of AIDS was not initially known, it was not possible to test for the presence of the virus or antibodies to the virus. Consequently, the concept of universal precautions was developed where all biological specimens should be considered potentially infectious and precautions were recommended that should be followed universally. These precautions included wearing gloves when handling blood specimens or other body fluids, wearing gowns and hand washing. After HIV was determined to cause AIDS it was found that the virus could be isolated from several bodily fluids including blood, semen, saliva, tears etc. and it was recognized that healthcare workers were at increased risk of infection when providing care for these patients. The initial universal precautions guidelines have been updated several times, emphasizing ". . . the need to treat blood and other body fluids from ALL patients as potentially infective"[@bib3].

While infectious diseases have always been present in pathology samples, the AIDS epidemic increased awareness of the need for robust safety protocols. Universal precautions were widely adopted including the use of cut resistant gloves, which significantly decrease hand injuries[@bib4]. The importance of using universal precautions was highlighted in one small study where two cases with no known risk factors were found to be positive for HIV at autopsy[@bib5]. The exposure to other infectious diseases, such as hepatitis, is even greater than the potential transmission of HIV[@bib6]. This emphasizes the need to use universal precautions for all autopsies, not just those known to be potentially infectious. The importance of using universal precautions during the COVID-19 pandemic needs to be reinforced. The concept of healthcare workers wearing personal protective equipment (PPE) frequently appears in the lay press during the 2020 COVID-19 pandemic, even when collecting nasopharyngeal swabs.Other infectious diseases potentially transmissible during an autopsy

Another culprit for autopsy-related infections includes tuberculosis. Cases of people obtaining tuberculosis (TB) during autopsies have been documented since the 18th century and continues to occur[@bib7]. Compared to the general population, the occupational risk for developing TB for laboratory and postmortem room staff is estimated to be 100-200 times greater[@bib8]. While the incidence of TB being present at autopsy has decreased due to the lower worldwide prevalence of the disease, it is still a hazard and highlights the need for universal precautions. Other bacterial infections may cause morbidity and mortality at the autopsy. There have been reports of medical students and physicians acquiring Streptococcus pyogenes infections following superficial injuries[@bib9].

Hepatitis B viral (HBV) infection is a highly infectious illness primarily transmitted through percutaneous or mucosal exposure to infected blood or other bodily fluids. Transmission may occur perinatally, sexually, and parenterally. Prior to the availability of a vaccine in 1982, an estimated 200,000-300,000 persons in the US were infected annually with hepatitis B[@bib10]. After the vaccine became available, mandatory screening of pregnant women for the presence of the hepatitis B surface Antigen (HBsAg) and universal vaccination of newborns was implemented in the 1990s resulting in a 10 fold reduction in HBV infections. The peak incidence of reported acute HBV infection was 11.5 per 100,000 in 1985[@bib11]. Following updated vaccine and testing protocols, the incidence has steadily declined to 0.9 per 100,000 in 2014[@bib12]. It should be noted that even with the decrease in the overall incidence, the prevalence and incidence of hepatitis B infection among health care workers is much higher than the general population, with pathologists and laboratory technicians being among those with the highest risk of infection[@bib13]. For healthcare workers, the CDC recommends vaccination, followed by anti-HBs serologic testing 1-2 months after the final dose. Vaccination should be done in any healthcare worker lacking documented evidence of a complete hepatitis B vaccine series, or those who lack an up-to-date blood test that shows immunity[@bib10]. Such regimens are required for both medical school and residency training in the United States. Another viral illness, hepatitis C, has been reported in health care workers and the rate of transmission after percutaneous exposure is 2.5 -- 10% (compared to a value of 0.3% with HIV exposures[@bib13]). A diligent search of the literature did not find any reported cases of hepatitis being transmitted during autopsy procedures.

Another group of infectious diseases potentially transmitted during autopsy are the Transmissible Spongiform Encephalopathies such as Creutzfield-Jakob disease. These are particularly relevant since a postmortem examination remains essential in confirming the clinical diagnosis. However, caution must be followed since the agents that cause Creutzfield-Jakob disease are highly resistant to disinfection protocols and even tissue from paraffin-embedded blocks can cause disease. Current World Health Organization (WHO) guidelines advocate the use of proper PPE as well as the limitation of aerosol production. The use of electric saws are discouraged unless appropriate protocols are followed[@bib14]. Limiting bone sawing has been suggested since both human and veterinary autopsy procedures generate aerosols[@bib15] ^,^ [@bib16]. Despite these concerns, appropriate protocols, such as the use of purified air powered respirators and placing the head inside a transparent plastic bag, provide protection from personnel in the autopsy suite. After the outbreak of "mad cow disease" in England, several countries initiated surveillance programs by performing brain autopsies in suspected cases. The reports of these programs do not mention any transmission to autopsy personnel[@bib17] ^,^ [@bib18]. A French study also did not show any transfusion associated cases, showing that the transmissibility is low[@bib19].

Transmission of respiratory pathogens, including SARS-CoV2

Of course the current SARS-CoV2 is predominantly a respiratory pathogen so comparisons should be made with related pulmonary pathogens, i.e. the original SARS virus (SARS-CoV) and the Middle East Respiratory Syndrome virus (MERS-CoV). The published data reassures that the risk of transmission to pathologists is low. A report showed that there were no cases of the original SARS transmission to healthcare workers in the USA, even though SARS patients were cared for in this country[@bib20]. An epidemiology report examined the transmission of SARS-CoV and MERS-CoV to health care personnel. This report documented that as of August 2015, worldwide there were 8096 cases of SARS-CoV and 1382 cases of MER-CoV. Despite the number of patients, there did not appear to be any cases of coronavirus transmission to laboratory personnel[@bib21].

The original SARS-CoV virus has been found in multiple tissues at autopsy, although the highest concentrations were in the lungs and small bowel[@bib22]. Formalin fixed tissue, or samples that have been processed for histology\\cytology\\electron microscopy may be handled using biosafety level 2 precautions[@bib23]. The most significant issue will be to reduce the production of aerosols especially when doing frozen sections. With the current COVID19 disease, environmental contamination has been documented[@bib24].

Effectiveness of universal precautions {#sec2}
======================================

One study examined the effectiveness of universal precautions by spiking patient samples with a non-pathogenic microbe and having technicians prepare the sample for routine lab testing. This simulation showed a 1% contamination rate in the laboratory personnel who handled the specimens, demonstrating that universal precautions provide a high level of effectiveness[@bib25]. The danger of performing autopsies on AIDS patient is virtually non-existent with only 1 reported case of autopsy transmission of HIV to a pathologist[@bib26].

An important, and disturbing, feature of COVID-19 is the presence of the virus in asymptomatic or pre-symptomatic individuals[@bib27]. It is possible that a patient dying of other causes, such as a person with atherosclerotic cardiovascular disease, could harbor the virus. Rather than test every autopsy for potential infectious diseases, it is more practical to adopt universal precautions for all autopsies. A recent response to a listserve of pathologists performing autopsies demonstrated that the risk of transmission is very low, i.e. 1 out of 675 person-exposures. The office performing that autopsy stated that the exposure more likely occurred in the community rather than during the autopsy[@bib28].

Current recommendations for performing COVID-19 autopsies {#sec2.1}
---------------------------------------------------------

Universal precautions have been outlined by the Center of Disease Control and Prevention. These guidelines cover autopsy practice, as well as the fields of surgical pathology and clinical pathology[@bib29]. The CDC website should be consulted since the guidelines may evolve as we learn more about the virus (<https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-postmortem-specimens.html>, updated June 15, 2020, accessed August 6, 2020). The guidelines include the recommended biosafety level for performing autopsies, the use of personal protective equipment (PPE) as well as use of instruments during procedures. Regarding the appropriate biosafety level, all autopsies would be safest when performed at biosafety level (BSL) 3. If a BSL-3 facility is not available, autopsies can be performed using the barrier precautions of BSL-2 plus negative airflow and the respiratory precautions of BSL-3. During autopsy procedures one should wear a fluid-resistant (surgical) jumpsuit or shirt and pants that cover from neck to feet and arms, waterproof apron and waterproof sleeves, closed-toe shoes covered with fluidproof shoe covers or booties, and a surgical cap or hood bonnet that entirely covers the head. Double-gloving is recommended, with cut-resistant gloves of fine woven steel covered by rubber gloves. In addition, one should wear at least a NIOSH-approved disposable N-95, or higher respirator. Those who cannot wear an N-95 must wear a Purified Air Powered Respiratory (PAPR). For removal of the brain, aerosol generation should be minimized by avoiding use of oscillating saws if possible, moistening the bone before cutting, and using vacuum attachments if an oscillating saw it to be used. There are also additional recommendations specifically for microbiological and biomedical laboratories[@bib30]. In the face of the new COVID19 pandemic, there are interim guidelines that highlight the importance of following proper standards as well as biosafety precautions[@bib31]. These guidelines specify that all autopsies on decedents known or suspected to be COVID-19 cases should be conducted in a negative pressure room, with a minimum of 6 air changes per hour for existing structures and 12 air changes per hour for renovated or new structures[@bib32].

Other countries have published guidelines regarding handling bodies and performing autopsies on COVID patients. In Germany, they recommend that when a body is being moved, either to or from the morgue, the mouth and face should be covered by surgical masks. Before and after autopsy procedures, all wound openings should be cleaned, disinfected, and covered with a waterproof band aid. In addition, the body orifices (mouth, nose, and anus) should be plugged with cotton or gauze soaked in 3000-5000 mg/L chlorine containing disinfectant or 0.5% peroxyacetic acid. The body should then be washed, sprayed with a 1/10 disinfectant-water solution, placed in a corpse bag which is closed and sprayed with a washing solution of 1/10 disinfectant-water[@bib33]. China and India have similar guidelines for cleaning and disinfecting of bodies, and the United States also requires the use of body bags for transporting bodies to and from the morgue[@bib34]. Per current USA CDC guidelines, the exterior surface of these body bags should be disinfected with EPA-approved disinfectants that meet the criteria for use against SARS-CoV-2. These guidelines also discuss the possibility of using minimally invasive autopsies. They can be performed to obtain the necessary samples in patients with widespread signs of infection, but should be supported with postmortem imaging. These safety considerations were also discussed in a 2020 paper[@bib23].

Value of performing COVID-19 autopsies {#sec3}
======================================

Given the potential infectious nature of any autopsy some may question the value of conducting these studies. Several recent examples show the substantial public health benefits of performing autopsies during this time. A 2019 New Eng J of Med commentary outlined the value of the autopsy[@bib35]. During the 1918 Spanish flu pandemic bacterial pneumonia caused the majority of deaths, information that would not have been documented without autopsies[@bib36]. Autopsies in patients with HIV revealed a striking incidence of tuberculosis, findings that impact recommendations for treatment[@bib37]. Multiple groups have been requesting autopsy specimens to examine the pathogenesis of the disease and are actively creating biobanks that will allow the sharing of resources[@bib38] ^,^ [@bib39].

There are several recent reports of autopsy findings in COVID-19 patients that have helped define the pathogenesis of the SARS-CoV2 infection. A complete autopsy examines multiple organs and tissues, including examination of the brain. Such detailed studies are not possible when the patient is alive since it would involve numerous biopsies in critically ill patients. One autopsy series detailed the cardiovascular findings in COVID-19 patients[@bib40]. A report of 10 cases in New Orleans found thrombotic changes in the lungs[@bib41]. A review of 80 autopsies of COVID-19 patients in Germany detailed the comorbidities and found 40% of the patients had evidence of deep venous thrombi[@bib42]. Given the need to understand the host response, there has been a call to action to perform autopsies and describe the extent of organ involvement[@bib43]. Autopsies may provide biospecimens that will be useful to study the disease. To determine whether biospecimens from COVID-19 patients were being collected during the current pandemic, a survey was sent to the Association of Pathology Chairs listserve and 59 institutions responded. Of the 50 respondents who maintain biobanks, 45 were collecting specimens from COVID-19 patients. In one of the comments an institution had already distributed over 10,000 aliquots of specimens to investigators.

Conclusion: Autopsies may provide important public health information during the COVID-19 outbreak. With appropriate precautions, there is limited danger to autopsy personnel. All autopsies should use a universal protocol to protect pathology personnel, regardless of the known presence of infectious disease.
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